Card processing for qualifying B2C and B2B peptide businesses
Qualifying consumer-facing and B2B peptide businesses can accept card payments through processors Cybin works with. We review the actual file and compare card, ACH, and eCheck options; the processor or acquiring bank makes the underwriting decision.
Why peptide files receive extra review
Peptide processing is file-specific. The catalog, claims, customer controls, fulfillment, geography, and processing history can all affect which providers will review the business and which payment rails they may offer.
FDA enforcement on specific compounds
The product catalog and marketing language can create regulatory questions. Processors review the actual products and claims rather than relying on the category label alone.
Reputational risk for acquiring banks
Acquiring banks may apply different risk appetites to the same file. Accurate positioning and supporting documentation help the reviewer understand the business being presented.
Elevated chargeback rates
Long fulfillment windows, international shipping, or product-condition disputes can increase chargeback exposure. Clear delivery and refund policies help underwriters evaluate those risks.
Processor category sweeps
Processor policies and risk appetites can change. A current processor-fit review is more useful than assuming every provider treats the category the same way.
What processor underwriters review
Legal and compliance requirements depend on the product, intended use, and jurisdiction. From a payment perspective, reviewers focus on whether the catalog, marketing, customer controls, and supporting documents tell one accurate story.
What strengthens a file
- •Accurate intended-use labeling that matches the products and business model
- •Clear customer-access and eligibility controls where the model calls for them
- •Marketing claims supported by the products and applicable requirements
- •Current product and testing documentation when a processor requests it
- •Traceable supplier and sourcing records
- •Consistent product pages, checkout language, and social content
Common review blockers
- •Intended-use language that conflicts with the product or business model
- •Unsupported health, performance, or outcome claims
- •Testimonials or imagery that conflict with the represented use
- •Products or claims outside a processor's current policy
- •Missing documentation requested for the actual catalog
- •Website, checkout, or social content that tells an inconsistent story
Documents a processor may request
No documents are required to start Cybin's initial review. If a processor needs supporting material, the exact request will depend on the products, model, geography, ownership, and processing history in the file.
Certificates of Analysis (COAs)
A processor may request current third-party testing or product documentation for some or all of the catalog.
RUO labeling proof
Screenshots or samples may be requested when intended-use labeling is relevant to the business model being reviewed.
Supplier agreements
Contracts, invoices, or purchase orders may be used to document sourcing and the commercial relationship.
Business formation docs
Formation documents, EIN records, ownership information, and applicable licenses may be requested during underwriting.
Bank statements (3-6 months)
These are not required to start. A processor may request statements to evaluate volume, cash flow, disputes, or prior processing.
Compliant website
Reviewers may check product pages, terms, privacy, refund, shipping, contact information, claims, and checkout disclosures.
How MCC classification is handled
The processor or acquiring bank assigns the Merchant Category Code from the actual products, customers, and business model. The examples below can arise in adjacent models, but no code is automatically correct for every peptide merchant.
Laboratory / Scientific Supplies
May be considered for some laboratory or scientific-supply models when it accurately reflects the business.
Drugs, Drug Proprietaries & Sundries
May be considered for some catalogs in this broader classification. The acquirer decides whether it accurately applies.
Miscellaneous Specialty Retail
May be considered for some specialty-retail models. It is not a substitute for accurate disclosure of the catalog.
Card-first options with complementary payment rails
Qualifying consumer-facing and B2B peptide merchants may have card-processing options. ACH, eCheck, or an additional approved account can complement cards and reduce concentration risk, but no setup eliminates holds or interruptions.
- 1
Card processing based on the actual file
Domestic or offshore processor options may be considered depending on the catalog, claims, customer controls, geography, volume, and history. Written pricing and reserve terms come from the provider after review.
- 2
ACH or eCheck as a complementary rail
Bank-payment options may support larger tickets or provide customers another way to pay. Availability, settlement, returns, and pricing depend on the provider and business model.
- 3
An additional approved account when useful
A second approved provider can reduce reliance on one account. It does not guarantee continuity, and each account must accurately disclose and process the business approved for it.
- 4
Other payment methods when supported
Additional methods may be considered when they fit the customers, checkout, geography, and provider policy. We compare the written terms before you choose.
Chargeback prevention for peptide merchants
Peptide merchants face chargeback pressure from custom synthesis timelines, international shipping delays, and temperature-sensitive logistics. Here is the prevention practices we discuss with merchants when they fit the business.
Clear fulfillment timelines
Set accurate delivery expectations before payment and keep customers updated when fulfillment changes.
Tracking and signature confirmation
Use tracking and, when appropriate for the order value and risk, signature confirmation. Keep delivery evidence available for disputes.
Early alert services (Ethoca + Verifi)
Where supported, alert services can surface some disputes earlier and give the merchant time to review the transaction.
Descriptor clarity
Use a recognizable descriptor approved for the account and make support information easy to find.
Free to merchants
Consultation, application review, and processor matching are free. We are compensated by processors when accounts onboard — never by you.
RUO category expertise
We review the catalog, claims, customer controls, sourcing, geography, and processing history before identifying processor-fit options.
Honest read on your file
We tell you upfront if your product catalog, website content, or documentation will cause problems — and what to fix before applying.
Peptide merchant account FAQs
Can research peptide merchants get payment processing?
Yes. Qualifying consumer-facing and B2B peptide businesses can accept card payments through processors Cybin works with. B2C status alone is not a disqualifier. The processor reviews the catalog, marketing claims, customer controls, licensing where applicable, geography, sourcing, and processing history before deciding approval and terms.
What documentation do peptide merchants need for underwriting?
A processor may request product documentation, relevant labeling, supplier records, business formation documents, bank statements, processing history, and website policies. The exact checklist depends on the catalog, business model, geography, and processor. No documents are required to start Cybin's initial review.
Why do payment processors decline peptide merchants?
Peptide files can receive extra review because the product catalog, marketing claims, customer controls, fulfillment model, geography, dispute history, and processor policy all affect risk. A decline from one provider does not establish what every processor will decide.
What MCC codes are used for peptide merchant accounts?
The processor or acquiring bank assigns the MCC based on the merchant's actual products, customers, and business model. Laboratory supplies, specialty retail, and other classifications may be considered, but no single MCC applies to every peptide business. The final classification must accurately reflect the business being underwritten.
How long does it take to get approved for a peptide merchant account?
Underwriting timing varies by processor and file complexity and starts after the processor has a complete application. Requests for product, compliance, ownership, or processing-history documents can add time. The processor or acquiring bank makes the underwriting decision and controls final timing.
Related high-risk verticals
Cybin reviews payment options across the peptides and research category. The processor or acquiring bank makes each underwriting decision:
Ready to get your peptide business processing?
Start with a processor-fit review; no documents are required to start. We'll review the basics and request relevant product or compliance material only if it is needed for the next step.